158 related articles for article (PubMed ID: 6105677)
1. MSH and MIF-I in animal models of tardive dyskinesia.
Davis KL; Kastin AJ; Beilstein BA; Vento AL
Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
[TBL] [Abstract][Full Text] [Related]
2. Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats.
Hara C; Kastin AJ
Pharmacol Biochem Behav; 1986 Oct; 25(4):757-61. PubMed ID: 2878442
[TBL] [Abstract][Full Text] [Related]
3. Alpha-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas.
Kostrzewa RM; Kastin AJ; Spirtes MA
Pharmacol Biochem Behav; 1975; 3(6):1017-23. PubMed ID: 4815
[TBL] [Abstract][Full Text] [Related]
4. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia.
Yarbrough GG; Faison EP; Antolik EK
Neurosci Lett; 1982 Dec; 34(3):321-3. PubMed ID: 6819493
[TBL] [Abstract][Full Text] [Related]
5. Interaction of alpha-MSH and MIF-I with amphetamine on open-field behavior of rats.
Sandman CA; Kastin AJ
Pharmacol Biochem Behav; 1978 Dec; 9(6):759-62. PubMed ID: 34173
[No Abstract] [Full Text] [Related]
6. MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats.
Castellano JM; Batrynchuk J; Dolbeare K; Verma V; Mann A; Skoblenick KJ; Johnson RL; Mishra RK
Peptides; 2007 Oct; 28(10):2009-15. PubMed ID: 17766011
[TBL] [Abstract][Full Text] [Related]
7. A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.
Cox B; Kastin AJ; Schnieden H
Eur J Pharmacol; 1976 Mar; 36(1):141-7. PubMed ID: 4332
[TBL] [Abstract][Full Text] [Related]
8. Interaction of MIF-I or alpha-MSH with D-amphetamine or chlorpromazine on thermoregulation and motor activity of rats maintained at different ambient temperatures.
Yehuda S; Kastin AJ
Peptides; 1980; 1(3):243-8. PubMed ID: 6112734
[TBL] [Abstract][Full Text] [Related]
9. The pathophysiology of tardive dyskinesia.
Klawans HL; Carvey P; Tanner CM; Goetz CG
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
[TBL] [Abstract][Full Text] [Related]
10. MIF-1 attenuates apomorphine stereotypies in adult rats after neonatal 6-hydroxydopamine.
Kostrzewa RM; White TG; Zadina JE; Kastin AJ
Eur J Pharmacol; 1989 Apr; 163(1):33-42. PubMed ID: 2568266
[TBL] [Abstract][Full Text] [Related]
11. Choline chloride in animal models of tardive dyskinesia.
Davis KL; Hollister LE; Vento AL; Simonton S
Life Sci; 1978 May; 22(19):1699-707. PubMed ID: 566830
[No Abstract] [Full Text] [Related]
12. Modification of d-amphetamine- or chlorpromazine-induced hypothermia by beta-endorphin, MIF-I, and alpha-MSH: mediation by the dopaminergic system.
Yehuda S; Carasso RL
Peptides; 1982; 3(2):105-10. PubMed ID: 6124951
[TBL] [Abstract][Full Text] [Related]
13. Dimethylaminoethanol (deanol): effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesia.
Davis KL; Hollister LE; Vento AL; Beilstein BA; Rosekind GR
Psychopharmacology (Berl); 1979 May; 63(2):143-6. PubMed ID: 112632
[TBL] [Abstract][Full Text] [Related]
14. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
Ott MC; Mishra RK; Johnson RL
Brain Res; 1996 Oct; 737(1-2):287-91. PubMed ID: 8930377
[TBL] [Abstract][Full Text] [Related]
15. alpha-MSH and MIF-I effects on cGMP levels in various rat brain regions.
Spirtes MA; Christensen CW; Harston CT; Kastin AJ
Brain Res; 1978 Apr; 144(1):189-93. PubMed ID: 25119
[No Abstract] [Full Text] [Related]
16. Increased acquisition of a complex appetitive task after MSH and MIF.
Stratton LO; Kastin AJ
Pharmacol Biochem Behav; 1975; 3(5):901-4. PubMed ID: 1801
[TBL] [Abstract][Full Text] [Related]
17. Influence of three short-chain peptides (alpha-MSH, MSH/ACTH 4-10, MIF-I on) dimensional attention.
Beckwith BE; Sandman CA; Kastin A
Pharmacol Biochem Behav; 1976; 5(Suppl 1):11-6. PubMed ID: 13409
[TBL] [Abstract][Full Text] [Related]
18. alpha-MSH, MIF-I and melatonin: effects on novelty-induced defecation, plasma 11-OHCS and central catecholamines in rats.
Datta PC; King MG
Peptides; 1981; 2 Suppl 1():143-54. PubMed ID: 6115365
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia.
Gattaz WF; Emrich A; Behrens S
J Neural Transm Gen Sect; 1993; 92(2-3):197-201. PubMed ID: 8369109
[TBL] [Abstract][Full Text] [Related]
20. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia.
Koller W; Curtin J; Fields J
Neuropharmacology; 1984 Oct; 23(10):1191-4. PubMed ID: 6240609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
